HealthTech & MedTech
Translating complex clinical audiology and diagnostic patents into commanding global market leadership and patient-centric value.
A creative management consultancy solving upstream commercial challenges for CEOs, boards, and private equity investors. Brand as direction, not decoration.
“HAVING A GREAT BRAND MEANS YOU GET TO PLAY THE GAME OF CAPITALISM ON EASY MODE.”
Where category commoditisation, M&A friction, and pricing pressure erode balance-sheet margins.
Translating complex clinical audiology and diagnostic patents into commanding global market leadership and patient-centric value.
Restructuring sprawling international acquisitions and disparate P&Ls into unified, high-margin strategic talent powerhouses.
Dismantling fear-based IT clichés to reframe continuous compliance into board-level balance sheet resilience and predictable recurring revenue.
Repositioning commoditised baking ingredients into essential functional wellness to unlock multi-million non-baking consumption occasions.
Unifying dozens of autonomous supply-chain entities under a shared high-conviction narrative for institutional investor exit readiness.
Scaling extreme autonomous search-and-rescue marine engineering into a multi-billion-pound global investable technology platform.
Grounding commercial real estate IoT digital twins in mathematical physics and fiduciary duty to protect against stranded assets.
Repositioning residential adventure from vulnerable end-of-term leisure into indispensable state-aligned educational curriculum partner.
Empirical results delivered for CEOs, executive committees, and private equity sponsors ahead of major liquidity events.
Re-engineered the operating model of a £3 billion workforce giant, eliminating internal margin cannibalisation across 18 fragmented acquisitions ahead of ONEX majority buyout.
“NOKAMO’s work provided the backbone for all future decision-making, direction and growth.” Ged Mason OBE — CEO, Morson GroupRead Full Case Study →
Bypassed hooded-hacker fear marketing to establish the provocative ‘Business As Normal’ commercial thesis, unlocking scalable recurring subscription revenue.
“This positioning provided a pivotal competitive advantage for our investors and commercial teams.” Wayne Churchill — CEO, NormCyberRead Full Case Study →
Repositioned a commoditised British baking supplier into a science-backed ‘Nutrient Powerhouse’, driving double-digit grocery sales growth and pre-tax profitability.
“We needed a strategy applicable for everyone from the CFO to the forklift driver. Ian delivered.” Chief Executive Officer — WhitworthsRead Full Case Study →
“For us, brand and business strategy are one and the same, and this work has given us a backbone for all future decision-making, direction and growth.”
An interconnected methodology ensuring board-level commercial decisions translate into organisational reality.
Corporate, brand, and marketing strategy to defend margins, align M&A, and prepare for institutional liquidity events.
The design of tangible, value-creating business solutions that express commercial strategy with unmistakable signal.
Zero-dependency organisational launch programmes that embed strategic direction without permanent consultancy lock-in.
From messy upstream problem diagnosis to zero-dependency execution across teams and international markets.
Direct C-suite sparring and commercial audit to isolate the true underlying constraint limiting enterprise valuation, customer retention, or pricing power.
Grounded in empirical marketing science (Ehrenberg-Bass, Binet & Field), we architect a single attacking commercial principle that commands board consensus.
Designing unmistakable identity systems, product naming conventions, and value propositions that make your company mathematically non-replicable.
Operationalising through internal academies, automated deployment tools, and clear KPIs so your leadership team owns and scales the asset independently.
Led by former agency founders, FTSE commercial directors, and DBA/RSA professors.
Serial entrepreneur. Co-founded LIFE and Twelve agencies, managing tier-one multinational accounts before completing a trade sale to Communisis PLC. Uncompromising advocate of brand as an economic engine.
Former owner and Chairman of Elmwood. Former Chair of Design Business Association (DBA), RSA Council Member, Visiting Professor of Innovation at Huddersfield University, awarded OBE for services to design.
Founding partner with 15+ years steering complex global accounts across sensitive categories including advanced oncology immunotherapy and healthcare innovation.
Senior brand strategist specialising in high-growth technology scale-ups, B2B margin defense against commoditisation, and multinational medical device launches.
Verbatim evaluations from enterprise leaders, academics, and private equity investors.
“NOKAMO offer a valuable corrective to most consultancies’ downright nonsense.”
“NOKAMO offer the perfect blend of business gravitas and creativity.”
“Practical realism versus starry-eyed optimism, this is already supercharging sales teams and customer engagement.”
Challenging conventional marketing fallacies with empirical evidence and commercial reality.
Investigating why 91% of corporate decision-makers fail to connect brand to balance-sheet valuation, and why 49% still confuse brand strategy with a visual logo facelift.
Request Executive Copy →
A rigorous playbook for venture-backed and growth-stage founders confronting the growth plateau, customer acquisition cost inflation, and market positioning traps.
Request Executive Copy →
How institutional investors and chairpersons weave defensible intangible brand equity into financial metrics ahead of trade sale auctions or secondary buyouts.
Request Executive Copy →Direct, answer-first clarity on engagement models, timelines, and enterprise governance.
We operate as management consultants, not advertising vendor shops. We solve upstream commercial challenges—such as M&A portfolio alignment, P&L consolidation, and exit readiness—before traditional creative briefs exist. Aesthetics are subordinated to balance-sheet valuation, pricing power, and empirical marketing science.
Our engagements are mandated directly by CEOs, executive committees, and private equity sponsors. Clients typically range from high-growth technology scale-ups seeking £100m+ valuations to multi-billion-pound conglomerates (£3B+ turnover) requiring complex brand rationalisation and post-merger integration.
We deploy high-intensity strategic sprints (5-week rapid transformations for urgent exit readiness or investor conferences) as well as comprehensive multi-stage programmes spanning diagnostic immersion, strategy formulation, and organizational rollout over 3 to 6 months.
Our Deployment practice is explicitly engineered around zero-dependency principles. Through custom employee upskilling programmes and our Brand BrAIn Auto Marketeer™ system, we hand complete ownership of the strategic asset back to your internal teams without mandatory ongoing retainers.
Spar directly with Ian Humphris and the executive partners. No junior account handlers, no generic slide decks.
020 3006 2100 (Central) / 07788 727 381 (Direct)
Monday – Sunday: 9:00 AM – 5:30 PM GMT
Bennetts Hill House, 24 Bennetts Hill, Birmingham, B2 5QP, United Kingdom
Direct engagement with our senior partners regarding commercial strategy, brand architecture, or exit readiness.